| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1018088034 |
| P356 | DOI | 10.1186/1755-8794-3-33 |
| P932 | PMC publication ID | 2924253 |
| P698 | PubMed publication ID | 20687937 |
| P5875 | ResearchGate publication ID | 45507336 |
| P50 | author | Christopher G Bell | Q37829927 |
| Peter Maxwell | Q38545687 | ||
| P2093 | author name string | Stephan Beck | |
| Vardhman K Rakyan | |||
| Andrew E Teschendorff | |||
| David A Savage | |||
| P2860 | cites work | Bioconductor: open software development for computational biology and bioinformatics | Q21194861 |
| Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 | ||
| A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters | Q24537436 | ||
| DNA methylation profiling of human chromosomes 6, 20 and 22 | Q24607522 | ||
| Human DNA methylomes at base resolution show widespread epigenomic differences | Q24633677 | ||
| The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores | Q24649374 | ||
| A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis | Q24651226 | ||
| Statistical significance for genomewide studies | Q24681264 | ||
| Rab34 and its effector munc13-2 constitute a new pathway modulating protein secretion in the cellular response to hyperglycemia | Q28116004 | ||
| A genome-wide association study identifies novel risk loci for type 2 diabetes | Q28287727 | ||
| Inherited epigenetic variation--revisiting soft inheritance | Q28301797 | ||
| Capturing heterogeneity in gene expression studies by surrogate variable analysis | Q28469315 | ||
| A common variant on chromosome 9p21 affects the risk of myocardial infarction | Q29614954 | ||
| DNA methylation landscapes: provocative insights from epigenomics | Q29617144 | ||
| Confirmation of genetic associations at ELMO1 in the GoKinD collection supports its role as a susceptibility gene in diabetic nephropathy | Q30434280 | ||
| Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes | Q30435965 | ||
| Variants in intron 13 of the ELMO1 gene are associated with diabetic nephropathy in African Americans | Q30436877 | ||
| An epigenetic signature in peripheral blood predicts active ovarian cancer | Q33519528 | ||
| Recent advancement of understanding pathogenesis of type 1 diabetes and potential relevance to diabetic nephropathy | Q34682220 | ||
| The methylome: approaches for global DNA methylation profiling | Q34759608 | ||
| Diabetes and the kidney | Q36267504 | ||
| High-density single nucleotide polymorphism genome-wide linkage scan for susceptibility genes for diabetic nephropathy in type 1 diabetes: discordant sibpair approach | Q36842660 | ||
| G/T substitution in intron 1 of the UNC13B gene is associated with increased risk of nephropathy in patients with type 1 diabetes | Q36906421 | ||
| Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a. | Q36967574 | ||
| The role of inflammatory cytokines in diabetic nephropathy. | Q37078749 | ||
| Multiple superoxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complicat | Q37127488 | ||
| Association of genetic variants at 3q22 with nephropathy in patients with type 1 diabetes mellitus | Q37156204 | ||
| Epigenetics and atherosclerosis | Q37398194 | ||
| Epigenetics in hyperhomocysteinemic states. A special focus on uremia. | Q37401983 | ||
| The epigenetic conductor: a genomic orchestrator in chronic kidney disease complications? | Q37575076 | ||
| AP-1 proteins mediate hyperglycemia-induced activation of the human TGF-beta1 promoter in mesangial cells. | Q38307181 | ||
| Genome-wide DNA methylation profiling using Infinium® assay | Q39793806 | ||
| High glucose blunts vascular endothelial growth factor response to hypoxia via the oxidative stress-regulated hypoxia-inducible factor/hypoxia-responsible element pathway | Q40295276 | ||
| Familial factors determine the development of diabetic nephropathy in patients with IDDM. | Q41152952 | ||
| Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy | Q41306582 | ||
| Atherosclerosis risk factors can impose aberrant DNA methylation patterns: a tale of traffic and homocysteine | Q43278838 | ||
| Epigenetics: new concepts of old phenomena in vascular physiology. | Q51933550 | ||
| Remarks on Parallel Analysis. | Q54260171 | ||
| R: A Language for Data Analysis and Graphics | Q56268347 | ||
| Altered Gene Expression Related to Glomerulogenesis and Podocyte Structure in Early Diabetic Nephropathy of db/db Mice and Its Restoration by Pioglitazone | Q61648746 | ||
| Diabetic nephropathy | Q73158257 | ||
| GoldenGate assay for DNA methylation profiling | Q79800232 | ||
| P921 | main subject | type-1 diabetes | Q124407 |
| DNA methylation | Q874745 | ||
| diabetic nephropathy | Q1129105 | ||
| P304 | page(s) | 33 | |
| P577 | publication date | 2010-08-05 | |
| P1433 | published in | BMC Medical Genomics | Q15754662 |
| P1476 | title | Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus | |
| P478 | volume | 3 |
| Q26769678 | A Systems Biology Overview on Human Diabetic Nephropathy: From Genetic Susceptibility to Post-Transcriptional and Post-Translational Modifications |
| Q34242041 | A comparison of feature selection and classification methods in DNA methylation studies using the Illumina Infinium platform. |
| Q58377105 | A whole genome methylation analysis of systemic lupus erythematosus: hypomethylation of the IL10 and IL1R2 promoters is associated with disease activity |
| Q58612380 | Aberrant DNA methylation of Tgfb1 in diabetic kidney mesangial cells |
| Q33904741 | Aberrant DNA methylation patterns in diabetic nephropathy |
| Q92416723 | Altered DNA methylation of TRIM13 in diabetic nephropathy suppresses mesangial collagen synthesis by promoting ubiquitination of CHOP |
| Q37359732 | Association between promoter methylation of serotonin transporter gene and depressive symptoms: a monozygotic twin study |
| Q34101704 | Batch effect correction for genome-wide methylation data with Illumina Infinium platform |
| Q39017669 | Beyond Genetics: What Causes Type 1 Diabetes |
| Q38290083 | Biomarkers in diabetic nephropathy: Present and future |
| Q38013734 | Chromatin modifications associated with diabetes |
| Q38231978 | Comparative epigenomics: defining and utilizing epigenomic variations across species, time-course, and individuals. |
| Q33759128 | Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis |
| Q33907898 | Comparisons of non-Gaussian statistical models in DNA methylation analysis |
| Q45897795 | Comprehensive DNA methylation analysis of peripheral blood cells derived from patients with first-episode schizophrenia |
| Q37572161 | Coregulation and modulation of NFκB-related genes in celiac disease: uncovered aspects of gut mucosal inflammation |
| Q33747852 | Correlation of CTGF gene promoter methylation with CTGF expression in type 2 diabetes mellitus with or without nephropathy |
| Q34774905 | Cubilin expression is monoallelic and epigenetically augmented via PPARs |
| Q59447403 | Curcumin Modulates DNA Methyltransferase Functions in a Cellular Model of Diabetic Retinopathy |
| Q35085745 | Cutting edge: the etiology of autoimmune thyroid diseases |
| Q88513806 | Cytosine methylation predicts renal function decline in American Indians |
| Q33740666 | DNA hypermethylation and DNA hypomethylation is present at different loci in chronic kidney disease |
| Q38731470 | DNA methylation and its role in the pathogenesis of diabetes. |
| Q36156306 | DNA methylation at IL32 in juvenile idiopathic arthritis. |
| Q37668895 | DNA methylation profile associated with rapid decline in kidney function: findings from the CRIC study |
| Q37716900 | DNA methylation profiles in type 1 diabetes twins point to strong epigenetic effects on etiology |
| Q35874941 | DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from type 2 diabetic patients |
| Q54270202 | DNA methylation profiling of genomic DNA isolated from urine in diabetic chronic kidney disease: A pilot study. |
| Q33567569 | DNA methylation-based forensic age prediction using artificial neural networks and next generation sequencing |
| Q43876594 | Decreased urine albumin:creatinine ratios in infants of diabetic mothers: does exposure to diabetic pregnancies alter fetal renal development? |
| Q41993558 | Diabetic Nephropathy: a Tangled Web to Unweave |
| Q92501574 | Diabetic kidney disease: A systematic review on the role of epigenetics as diagnostic and prognostic marker |
| Q38227252 | Diabetic nephropathy--emerging epigenetic mechanisms |
| Q36441616 | Diabetic nephropathy: What does the future hold? |
| Q44831942 | Differential methylation in visceral adipose tissue of obese men discordant for metabolic disturbances |
| Q26741494 | Early detection of diabetic kidney disease: Present limitations and future perspectives |
| Q38073599 | Effects of early-life environment and epigenetics on cardiovascular disease risk in children: highlighting the role of twin studies |
| Q47159412 | Emerging Evidence of Epigenetic Modifications in Vascular Complication of Diabetes |
| Q36804126 | Empirical testing of hypotheses about the evolution of genomic imprinting in mammals |
| Q90025878 | Epigenetic Markers of Aging Predict the Neural Oscillations Serving Selective Attention |
| Q38747538 | Epigenetic Mechanisms in Diabetic Kidney Disease |
| Q60957108 | Epigenetic Modification Mechanisms Involved in Inflammation and Fibrosis in Renal Pathology |
| Q92221968 | Epigenetic Modifications in Peripheral Blood as Potential Noninvasive Biomarker of Diabetic Retinopathy |
| Q37733522 | Epigenetic Regulations in Diabetic Nephropathy |
| Q38080554 | Epigenetic changes in diabetes. |
| Q21134965 | Epigenetic mechanism underlying the development of polycystic ovary syndrome (PCOS)-like phenotypes in prenatally androgenized rhesus monkeys |
| Q35071700 | Epigenetic mechanisms in diabetic complications and metabolic memory |
| Q34986508 | Epigenetic mechanisms in diabetic vascular complications |
| Q37887378 | Epigenetic mechanisms. |
| Q36471772 | Epigenetic modifications and diabetic nephropathy. |
| Q21284810 | Epigenetic modifications and diabetic retinopathy |
| Q37158080 | Epigenetic modifications in the pathogenesis of diabetic nephropathy |
| Q38015802 | Epigenetic regulation and measurement of epigenetic changes |
| Q38297582 | Epigenetic roots of immunologic disease and new methods for examining chromatin regulatory pathways |
| Q38605096 | Epigenetics and Cardiovascular Disease in Diabetes. |
| Q57819275 | Epigenetics and Regulation of Oxidative Stress in Diabetic Retinopathy |
| Q92512595 | Epigenetics and epigenomics in diabetic kidney disease and metabolic memory |
| Q64063505 | Epigenetics in Human Obesity and Type 2 Diabetes |
| Q38062497 | Epigenetics in autoimmune diseases with focus on type 1 diabetes |
| Q47412518 | Epigenetics in diabetic nephropathy, immunity and metabolism. |
| Q34633331 | Epigenetics in kidney development and renal disease |
| Q51042250 | Epigenetics in type 1 diabetes: TNFa gene promoter methylation status in Chilean patients with type 1 diabetes mellitus. |
| Q37962602 | Epigenetics of autoimmune diabetes. |
| Q37986987 | Epigenetics: a tool to understand diet-related cardiovascular risk? |
| Q35068854 | Epigenetics: deciphering its role in diabetes and its chronic complications |
| Q28710498 | Epigenome-wide association studies for common human diseases |
| Q47801332 | Epigenome-wide association study for Parkinson's disease. |
| Q36961035 | Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT/EDIC type 1 diabetes cohort |
| Q64101212 | Evaluating DNA methylation age on the Illumina MethylationEPIC Bead Chip |
| Q24288692 | Gene-specific DNA methylation association with serum levels of C-reactive protein in African Americans |
| Q64911111 | Genetic and Epigenetic Studies in Diabetic Kidney Disease. |
| Q27024548 | Genetic and epigenetic factors influencing chronic kidney disease |
| Q87955785 | Genetic and epigenetic influences on the loss of tolerance in autoimmunity |
| Q36694689 | Genetic and epigenetic mechanisms in thyroid autoimmunity |
| Q28084549 | Genetics and Epigenetics of Diabetic Nephropathy |
| Q26752749 | Genetics of cardiovascular and renal complications in diabetes |
| Q38478054 | Genetics of diabetic nephropathy: a long road of discovery. |
| Q90182401 | Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen |
| Q40835446 | Genome-Wide Scan for Methylation Profiles in Keloids |
| Q38492236 | Genome-wide DNA methylation analysis in alcohol dependence |
| Q35451716 | Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells |
| Q35739097 | Genome-wide analysis of DNA methylation in subjects with type 1 diabetes identifies epigenetic modifications associated with proliferative diabetic retinopathy |
| Q37089130 | Genome-wide methylation profiling demonstrates hypermethylation in maternal leukocyte DNA in preeclamptic compared to normotensive pregnancies |
| Q57788041 | Genomic approaches in the search for molecular biomarkers in chronic kidney disease |
| Q35738101 | Global DNA methylation and risk of subclinical atherosclerosis in young adults: the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study |
| Q50790138 | Global DNA methylation as a possible biomarker for diabetic retinopathy. |
| Q33569693 | Glucose-induced metabolic memory in Schwann cells: prevention by PPAR agonists |
| Q38103744 | Glycemic memories and the epigenetic component of diabetic nephropathy |
| Q35696490 | Heritable transmission of diabetic metabolic memory in zebrafish correlates with DNA hypomethylation and aberrant gene expression |
| Q37153862 | High glucose-induced cytoplasmic translocation of Dnmt3a contributes to CTGF hypo-methylation in mesangial cells |
| Q51602719 | High-glucose environment increased thrombospondin-1 expression in keratinocytes via DNA hypomethylation. |
| Q38320756 | Human genetics of diabetic nephropathy |
| Q38247113 | Human genetics of diabetic retinopathy |
| Q27000709 | Human genetics of diabetic vascular complications |
| Q60953217 | Hypermethylated and its clinical significance in colorectal cancer |
| Q34590776 | Identification and functional validation of HPV-mediated hypermethylation in head and neck squamous cell carcinoma |
| Q99583849 | Identification of hub genes in diabetic kidney disease via multiple-microarray analysis |
| Q34042724 | Identification of type 1 diabetes-associated DNA methylation variable positions that precede disease diagnosis. |
| Q36100985 | Individual variation and longitudinal pattern of genome-wide DNA methylation from birth to the first two years of life |
| Q30718043 | Integration of data from omic studies with the literature-based discovery towards identification of novel treatments for neovascularization in diabetic retinopathy |
| Q92531853 | Kidney cytosine methylation changes improve renal function decline estimation in patients with diabetic kidney disease |
| Q34463827 | MAOA promoter methylation and susceptibility to carotid atherosclerosis: role of familial factors in a monozygotic twin sample |
| Q33812860 | Maternal genome-wide DNA methylation patterns and congenital heart defects |
| Q34202415 | MethLAB: a graphical user interface package for the analysis of array-based DNA methylation data |
| Q38206114 | Molecular mechanisms in autoimmune type 1 diabetes: a critical review. |
| Q37785319 | Molecular mechanisms in renal degenerative disease |
| Q36149231 | Normal early pregnancy: a transient state of epigenetic change favoring hypomethylation |
| Q37700231 | Novel insights into DNA methylation and its critical implications in diabetic vascular complications |
| Q38480783 | Oxidative stress and epigenetic modifications in the pathogenesis of diabetic retinopathy. |
| Q35647167 | Pharmacogenomics of cardiovascular complications in diabetes and obesity |
| Q57606412 | Progress in Defining the Genetic Basis of Diabetic Complications |
| Q35909055 | Recent developments in epigenetics of acute and chronic kidney diseases |
| Q35159041 | Remodeling is at the heart of chromatin: the heartaches of chromatin |
| Q27005625 | Risk factors and primary prevention trials for type 1 diabetes |
| Q50513319 | Role of DNA methylation at the placental RTL1 gene locus in type 1 diabetes |
| Q38059670 | Role of epigenetic mechanisms in the vascular complications of diabetes. |
| Q89060349 | Sex-specific epigenetic mediators between early life social disadvantage and adulthood BMI |
| Q38524836 | Skewed Epigenetics: An Alternative Therapeutic Option for Diabetes Complications |
| Q92494610 | Slowing Down Ageing: The Role of Nutrients and Microbiota in Modulation of the Epigenome |
| Q38701049 | The Emerging Role of DNA Methylation in Kidney Transplantation: A Perspective |
| Q52341285 | The Promise of Systems Biology for Diabetic Kidney Disease. |
| Q37808311 | The epigenomic interface between genome and environment in common complex diseases |
| Q38396875 | The genetics of diabetic complications |
| Q37590421 | The genetics of diabetic nephropathy. |
| Q35229122 | The potential use of DNA methylation biomarkers to identify risk and progression of type 2 diabetes |
| Q28389137 | The role of epigenetic mechanisms and processes in autoimmune disorders |
| Q84699899 | Tissue-specific alterations of methyl group metabolism with DNA hypermethylation in the Zucker (type 2) diabetic fatty rat |
| Q92309432 | Transcriptome Analysis and Emerging Driver Identification of CD8+ T Cells in Patients with Vitiligo |
| Q35832781 | Two-step epigenetic Mendelian randomization: a strategy for establishing the causal role of epigenetic processes in pathways to disease. |
| Q61816301 | Unveiling the Role of DNA Methylation in Kidney Transplantation: Novel Perspectives toward Biomarker Identification |
| Q27023289 | Using epigenetic mechanisms to understand the impact of common disease causing alleles |
| Q38058123 | Using epigenome-wide association scans of DNA methylation in age-related complex human traits |
| Q39446720 | Vascular complications in diabetes: old messages, new thoughts |
| Q21133557 | When is hub gene selection better than standard meta-analysis? |
| Q35019180 | Whole genome methylation array analysis reveals new aspects in Balkan endemic nephropathy etiology |
| Q60049158 | miR29b regulates aberrant methylation in In-Vitro diabetic nephropathy model of renal proximal tubular cells |
Search more.